Literature DB >> 2628161

Prednisonephobia.

R Patterson1, C L Walker, P A Greenberger, E P Sheridan.   

Abstract

The use of chronic systemic corticosteroids in allergic diseases should be restricted to cases where these agents are essential. Potentially fatal asthma and idiopathic anaphylaxis are examples of essential need for prednisone. The usual dose requirements on an alternate day regimen are often modest in these diseases, and complications of steroid therapy are minimal and are of no major concern particularly when the alternative may be a fatality. In spite of these facts, certain patients have a phobic response to the requirement for prednisone therapy. We report seven cases of prednisonephobia and classify this phobia as interpersonal, iatrogenic, bibliophilic, or parental. Some of these phobic reactions may seriously interfere with medical management or patient survival. An information sheet is included which may help certain of these patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628161     DOI: 10.2500/108854189778935773

Source DB:  PubMed          Journal:  Allergy Proc        ISSN: 1046-9354


  6 in total

1.  Stop tarnishing steroid and Chinese medicine.

Authors:  Kam Lun E Hon; Vivian Wing Yan Lee; Ting Fan Leung
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

Review 2.  Very high dose inhaled corticosteroids: panacea or poison?

Authors:  G Russell
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

3.  Determinants for asthma control, quality of life and use of complementary and alternative medicine in asthmatic pediatric patients in four cities.

Authors:  Kam Lun Hon; Yan Min Bao; Kate C Chan; Kin Wai Chau; Rong-Shan Chen; Kun Tat Gary Cheok; Wa Keung Chiu; Li Deng; Chun-Hui He; Kin Mui Ieong; Jeng Sum C Kung; Ping Lam; Shu Yan David Lam; Qun Ui Lee; So Lun Lee; Ting Fan Leung; Theresa N H Leung; Lei Shi; Ka Ka Siu; Wei-Ping Tan; Maggie Haitian Wang; Tak Wai Wong; Bao-Jing Wu; Ada Y F Yip; Yue-Jie Zheng; Daniel K Ng
Journal:  World J Pediatr       Date:  2018-07-25       Impact factor: 2.764

Review 4.  Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?

Authors:  Kam Lun Ellis Hon; Ting Fan Leung; Alexander K C Leung
Journal:  Drug Des Devel Ther       Date:  2014-06-26       Impact factor: 4.162

5.  A survey of patients' perspectives of steroid injection (ppyeojusa) in Korea.

Authors:  Bo-Mi Shin; Sung Jun Hong; Yun Hee Lim; Jae Hun Jeong; Ho Sik Moon; Hey Ran Choi; Sun Kyung Park; Richard Jin Woo Han; Jae Hun Kim
Journal:  Korean J Pain       Date:  2019-07-01

6.  TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.

Authors:  Leïla Moret; Emmanuelle Anthoine; Hélène Aubert-Wastiaux; Anne Le Rhun; Christophe Leux; Juliette Mazereeuw-Hautier; Jean-François Stalder; Sébastien Barbarot
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.